Aleks Engel | Director, REPAIR Impact Fund
Novo Holdings
Aleks Engel is a partner with Novo Holdings where he has worked for 10 years. He is the Director of the REPAIR Impact Fund, a founding board member of the AMR Action Fund, and a board member of Paratek Pharmaceuticals, a commercial anti-infectives company. Aleks is based in Boston
Appearances:
Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:00
Investors panel: Seeking returns from investing in anti-infectives
Panel of investors in AMR will discuss deal dynamics and areas of particular interest.
last published: 14/Nov/24 16:45 GMT
last published: 14/Nov/24 16:45 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events